Skip to main content
. Author manuscript; available in PMC: 2015 Feb 3.
Published in final edited form as: Mol Pharm. 2014 Jan 7;11(2):436–444. doi: 10.1021/mp400396k

Fig 2.

Fig 2

Target NFV plasma concentrations achieved pseudo steady-state by 30 minutes as exemplified by rats that simultaneously received three different rates of CsA infusion; data from all CsA infusion rates are not shown to enhance visual clarity (A). In addition, these target steady-state concentrations (average at 120 min.) were not significantly affected by the presence of CsA (B).